跳至主要内容
临床试验/EUCTR2007-000026-44-DK
EUCTR2007-000026-44-DK进行中(未招募)1 期

Hydroxyethylstarch induced coagulopathy and haemostatic potential of fibrinogen - in vivo placebo controlled clinical trial.

Aarhus Universityhospital0 个研究点目标入组 20 人开始时间: 2007年3月28日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Indication for cystektomia
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Anticoagulant treatment and use of acetylsalicyclic acid and/or NSAID within 2 days.
  • Abnormale preoperative coagulationsparametres (Thr, PP, APTT, D-dimer, Fibrinogen, AT, TT)
  • Disseminated cancer and/or metastasis
  • Amnestic informations or records on schaemic heart disease, claudicatio, universel arteriosklerosis
  • Amnestic informations on familar and/or previous tromboembolic event
  • Renal failure defined as clinical relevant abnomal levels of creatinine
  • Liver failure defined as clinical relevant abnomal levels of ALAT
  • Hypersensibility to Voluven, Haemocomplettan eller ingredient substances
  • Fertile women not using contraception (contraceptive pill, diaphragm, condom)

研究者

发起方
Aarhus Universityhospital

相似试验